Investigating the Adhesion of New Adhesive to the Skin

NCT ID: NCT03439176

Last Updated: 2020-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-15

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The adhesion of the new adhesive strips is investigated on healthy volunteers

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion visit:

* Introduction to the study
* Inclusion in study
* Baseline information is obtained
* Instruct subject to pre-strip of abdominal skin

Test visits 1-25 (up to maximum 25 visits per subject. (1-3 days after pre-stripping the abdominal skin):

* Baseline measurements are conducted on both sides of the stomach (TEWL, hydration, erythema, pH - 3 repeated measurements under each adhesive strip area (upper, middle and bottom of adhesive strip)
* Potential wetting of skin - shower/bicycle exercise (max 60 minutes) and after-wetting baseline measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Adhesive strips are weighted and applied
* Potential shower/bicycle exercise (max 60 minutes)
* Adhesive strips are removed at pre-defined timeslots (peel force measured)
* Discomfort when strip was peeled of is evaluated by subject (VAS)
* Measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Acclimatization ½
* Measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Adhesive strips are weighed
* Photo of adhesive strips

The subjects can be asked to apply and change strips every 24 hours between two test visits but for a maximum of 10 days between two visits. The strips should be applied at the same place every time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test of new adhesive strips

The subjects will test adhesives strips made of 4 different adhesives:

Standard adhesive 1 Standard adhesive 2 PL4 PL16-L

Group Type EXPERIMENTAL

Standard adhesive 1

Intervention Type OTHER

This strip contains a standard hydrocolloid adhesive found in ostomy devices

Standard adhesive 2

Intervention Type OTHER

This strip contains a standard hydrocolloid adhesive found in ostomy devices

PL4

Intervention Type OTHER

This strip contains a new adhesive

PL16-L

Intervention Type OTHER

This strip contains a new adhesive

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard adhesive 1

This strip contains a standard hydrocolloid adhesive found in ostomy devices

Intervention Type OTHER

Standard adhesive 2

This strip contains a standard hydrocolloid adhesive found in ostomy devices

Intervention Type OTHER

PL4

This strip contains a new adhesive

Intervention Type OTHER

PL16-L

This strip contains a new adhesive

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Have given written informed consent
2. Be at least 18 years of age and have full legal capacity
3. Have intact skin on the area used in the investigation

Exclusion Criteria

1. Currently receiving or have within the past 2 months received radio- and/or chemotherapy
2. Currently receiving or have within the past months received topical steroid treatment in the abdominal skin area or systemic steroid (tablet/injection) treatment.
3. Are pregnant or breastfeeding
4. Have dermatological problems in the abdominal area (assessed by investigator)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lene F Nielsen

Role: PRINCIPAL_INVESTIGATOR

Head of the pre-clinical department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coloplast A/S

Humlebæk, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP267_3_5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA